Tags: Crohn’s diseaseIL10Inflammatory Bowel Diseasechronic kidney diseasekidney failure
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
2 | The Conversation Science Alert Science news. Official account. Australia | ||
3 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
4 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
5 | Emily Cooke Live Science Health reporter. London, United Kingdom | ||
6 | Jason Mast STAT News Writing about science, medicine. | STAT+: Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases - 25 days ago STAT+: A rare disease program, portrayed as both lifeline and pharma handout, is set to expire - 3 months ago STAT+: FDA rejects Rocket Pharmaceuticals’ gene therapy for ultra-rare condition, another setback for field - 6 months ago STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution - 12 months ago STAT+: Peter Marks on creating Operation Warp Speed, but for rare diseases - about 1 year ago | |
7 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
8 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | 2024 PharmaVoice 100s: Rare Disease Warriors - about 2 months ago | |
9 | Randy Dotinga MedPage Today Indie scribbler, advocate.
Board member, @ahcj. San Diego | ||
10 | John Wilkerson STAT News STAT Washington correspondent. |